Sign In
Buy INMB
$1.32
-0.1000 (-7.04%)
At Close: Jun 03, 2026
LA JOLLA, Calif., July 20, 2020 -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that.
INmune Bio (NASDAQ:INMB) Trading Down 15.8%
05:40am, Saturday, 18'th Jul 2020
Shares of INmune Bio Inc (NASDAQ:INMB) dropped 15.8% during mid-day trading on Thursday . The stock traded as low as $13.03 and last traded at $10.99, approximately 104,136 shares changed hands during
INmune Bio, Inc. Prices Public Offering of Common Stock
01:15pm, Thursday, 16'th Jul 2020
LA JOLLA, Calif, July 16, 2020 -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune”), a clinical-stage immunology company focused on developing treatments that.
INmune Bio: Stronger Support From Alzheimer's Drug XPro1595
08:23am, Thursday, 16'th Jul 2020
INmune Bio's Alzheimer's drug XPro1595 reduced neuroinflammation in AD patients. The results were ahead of October guidance; probably the reason investors bid the price up so high.
INmune Bio, Inc. Announces Proposed Public Offering of Common Stock
08:10pm, Wednesday, 15'th Jul 2020
LA JOLLA, Calif., July 15, 2020 -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company” or “INmune Bio”), a clinical-stage immunology company focused on developing treatments that.
INmune Bio (NASDAQ:INMB) Shares Gap Up After Analyst Upgrade
01:52am, Wednesday, 15'th Jul 2020
INmune Bio Inc (NASDAQ:INMB)’s share price gapped up prior to trading on Tuesday after Roth Capital raised their price target on the stock from $13.00 to $26.00. The stock had previously closed at $
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent
12:00am, Wednesday, 15'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 14)
Altimmune Inc (NASDAQ: ALT...
Tiny Biotech Skyrockets To A Record High On Promising Alzheimer's News
06:29pm, Tuesday, 14'th Jul 2020
Inmune Bio stock skyrocketed to a record high Tuesday after the biotech company unveiled promising results for its Alzheimer's treatment. The drug targets inflammation in the brain.
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) * Altimmune Inc (NASDAQ: ALT) (announced positive pre
Vaccine Makers BioNTech, Moderna, And Novavax Set To Run Higher
12:00am, Tuesday, 14'th Jul 2020
Stocks Analysis by Harry Boxer covering: KB Home, Vaxart Inc, Novavax Inc, Altimmune Inc. Read Harry Boxer's latest article on Investing.com
XPro1595 reduces neuroinflammation by 40.6% in a brain fiber pathway important for learning and memoryLA JOLLA, Calif., July 13, 2020 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Compa
LA JOLLA, Calif., July 09, 2020 -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the.
LA JOLLA, Calif., June 25, 2020 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and...
Neurotez: Can Leptin Prove Beneficial for Alzheimer's Patients?
09:21am, Wednesday, 24'th Jun 2020
By Anita Dushyanth, PhD NASDAQ:INMB | NASDAQ:NTRP | TSX:PMN.TO Rethinking the approach to treat Alzheimer’s disease Both scientists and physicians are still wrestling with the idea of how to identif
Financial Analysis: INmune Bio (NASDAQ:INMB) and Applied Genetic Technologies (NASDAQ:AGTC)
01:48am, Friday, 19'th Jun 2020
INmune Bio (NASDAQ:INMB) and Applied Genetic Technologies (NASDAQ:AGTC) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the stre
